These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 35354499)
21. Geospatiotemporal and Causal Inferential Study of European Epidemiological Patterns of Cannabis- and Substance-Related Congenital Orofacial Anomalies. Reece AS; Hulse GK J Xenobiot; 2023 Feb; 13(1):42-74. PubMed ID: 36810431 [TBL] [Abstract][Full Text] [Related]
22. European Epidemiological Patterns of Cannabis- and Substance-Related Congenital Neurological Anomalies: Geospatiotemporal and Causal Inferential Study. Reece AS; Hulse GK Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36612763 [TBL] [Abstract][Full Text] [Related]
23. Letter to the editor on "Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017, parts 1-3". Chen FY; Barnes M; Lewis EC Arch Public Health; 2022 Jul; 80(1):172. PubMed ID: 35850921 [TBL] [Abstract][Full Text] [Related]
24. Cannabinoid and substance relationships of European congenital anomaly patterns: a space-time panel regression and causal inferential study. Reece AS; Hulse GK Environ Epigenet; 2022; 8(1):dvab015. PubMed ID: 35145760 [TBL] [Abstract][Full Text] [Related]
25. Epidemiological association of cannabinoid- and drug- exposures and sociodemographic factors with limb reduction defects across USA 1989-2016: A geotemporospatial study. Reece AS; Hulse GK Spat Spatiotemporal Epidemiol; 2022 Jun; 41():100480. PubMed ID: 35691647 [TBL] [Abstract][Full Text] [Related]
26. Congenital anomaly epidemiological correlates of Δ8THC across USA 2003-16: panel regression and causal inferential study. Reece AS; Hulse GK Environ Epigenet; 2022; 8(1):dvac012. PubMed ID: 35782486 [TBL] [Abstract][Full Text] [Related]
27. Epidemiology of Δ8THC-Related Carcinogenesis in USA: A Panel Regression and Causal Inferential Study. Reece AS; Hulse GK Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805384 [TBL] [Abstract][Full Text] [Related]
28. Clinical Epigenomic Explanation of the Epidemiology of Cannabinoid Genotoxicity Manifesting as Transgenerational Teratogenesis, Cancerogenesis and Aging Acceleration. Reece AS; Hulse GK Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36834053 [TBL] [Abstract][Full Text] [Related]
29. Epidemiological overview of multidimensional chromosomal and genome toxicity of cannabis exposure in congenital anomalies and cancer development. Reece AS; Hulse GK Sci Rep; 2021 Jul; 11(1):13892. PubMed ID: 34230557 [TBL] [Abstract][Full Text] [Related]
30. Chromothripsis and epigenomics complete causality criteria for cannabis- and addiction-connected carcinogenicity, congenital toxicity and heritable genotoxicity. Reece AS; Hulse GK Mutat Res; 2016 Jul; 789():15-25. PubMed ID: 27208973 [TBL] [Abstract][Full Text] [Related]
31. Broad Spectrum epidemiological contribution of cannabis and other substances to the teratological profile of northern New South Wales: geospatial and causal inference analysis. Reece AS; Hulse GK BMC Pharmacol Toxicol; 2020 Nov; 21(1):75. PubMed ID: 33183341 [TBL] [Abstract][Full Text] [Related]
32. Potency trends of Δ9-tetrahydrocannabinol, cannabidiol and cannabinol in cannabis in the Netherlands: 2005-15. Niesink RJ; Rigter S; Koeter MW; Brunt TM Addiction; 2015 Dec; 110(12):1941-50. PubMed ID: 26234170 [TBL] [Abstract][Full Text] [Related]
33. A randomised controlled trial of vaporised Δ Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105 [TBL] [Abstract][Full Text] [Related]
34. Epigenomic and Other Evidence for Cannabis-Induced Aging Contextualized in a Synthetic Epidemiologic Overview of Cannabinoid-Related Teratogenesis and Cannabinoid-Related Carcinogenesis. Reece AS; Hulse GK Int J Environ Res Public Health; 2022 Dec; 19(24):. PubMed ID: 36554603 [TBL] [Abstract][Full Text] [Related]
35. Novel Insights into Potential Cannabis-Related Cancerogenesis from Recent Key Whole Epigenome Screen of Cannabis Dependence and Withdrawal: Epidemiological Commentary and Explication of Schrott et al. Reece AS; Hulse GK Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672773 [TBL] [Abstract][Full Text] [Related]
36. Cannabis Teratology Explains Current Patterns of Coloradan Congenital Defects: The Contribution of Increased Cannabinoid Exposure to Rising Teratological Trends. Reece AS; Hulse GK Clin Pediatr (Phila); 2019 Sep; 58(10):1085-1123. PubMed ID: 31288542 [TBL] [Abstract][Full Text] [Related]
37. Analysis of cannabidiol (CBD) and THC in nonprescription consumer products: Implications for patients and practitioners. Miller OS; Elder EJ; Jones KJ; Gidal BE Epilepsy Behav; 2022 Feb; 127():108514. PubMed ID: 34998268 [TBL] [Abstract][Full Text] [Related]
38. Model-based analysis on systemic availability of co-administered cannabinoids after controlled vaporised administration. Liu Z; Galettis P; Broyd SJ; van Hell H; Greenwood LM; de Krey P; Steigler A; Zhu X; Schneider J; Solowij N; Martin JH Intern Med J; 2020 Jul; 50(7):846-853. PubMed ID: 31264294 [TBL] [Abstract][Full Text] [Related]
39. Quantitation of Δ8-THC, Δ9-THC, Cannabidiol and 10 Other Cannabinoids and Metabolites in Oral Fluid by HPLC-MS-MS. Lin L; Amaratunga P; Reed J; Huang P; Lemberg BL; Lemberg D J Anal Toxicol; 2022 Feb; 46(1):76-88. PubMed ID: 33270860 [TBL] [Abstract][Full Text] [Related]
40. Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. Ligresti A; Moriello AS; Starowicz K; Matias I; Pisanti S; De Petrocellis L; Laezza C; Portella G; Bifulco M; Di Marzo V J Pharmacol Exp Ther; 2006 Sep; 318(3):1375-87. PubMed ID: 16728591 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]